Update of the vascular model of AMD

被引:48
作者
Friedman, E [1 ]
机构
[1] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA
关键词
D O I
10.1136/bjo.2003.036277
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:161 / 163
页数:3
相关论文
共 29 条
[11]  
FRIEDMAN E, 1963, ARCH OPHTHALMOL-CHIC, V69, P220
[12]   The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration [J].
Friedman, E .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2000, 130 (05) :658-663
[13]  
FRIEDMAN E, 1977, CONTROVERSY OPHTHALM, P706
[14]  
Grunwald JE, 1998, INVEST OPHTH VIS SCI, V39, P385
[15]   Risk of macular degeneration in users of statins: cross sectional study [J].
Hall, NF ;
Gale, CR ;
Syddall, H ;
Phillips, DIW ;
Martyn, CN .
BRITISH MEDICAL JOURNAL, 2001, 323 (7309) :375-376
[16]   Alu DNA polymorphism in ACE gene is protective for age-related macular degeneration [J].
Hamdi, HK ;
Reznik, J ;
Castellon, R ;
Atilano, SR ;
Ong, JM ;
Udar, N ;
Tavis, JH ;
Aoki, AM ;
Nesburn, AB ;
Boyer, DS ;
Small, KW ;
Brown, DJ ;
Kenney, MC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 295 (03) :668-672
[17]   Hypertension, cardiovascular disease, and age-related macular degeneration [J].
Hyman, L ;
Schachat, AP ;
He, QM ;
Leske, MC .
ARCHIVES OF OPHTHALMOLOGY, 2000, 118 (03) :351-358
[18]   Relationship between refraction and prevalent as well as incident age-related maculopathy: The Rotterdam Study [J].
Ikram, MK ;
van Leeuwen, R ;
Vingerling, JR ;
Hofman, A ;
de Jong, PTVM .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (09) :3778-3782
[19]   Relation of statin use to the 5-year incidence and progression of age-related maculopathy [J].
Klein, R ;
Klein, BEK ;
Tomany, SC ;
Danforth, LG ;
Cruickshanks, KJ .
ARCHIVES OF OPHTHALMOLOGY, 2003, 121 (08) :1151-1155
[20]   Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy [J].
Malek, G ;
Li, CM ;
Guidry, C ;
Medeiros, NE ;
Curcio, CA .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (02) :413-425